CRAIL - Controlled Reperfusion of the Acutely Ischemic Limb — CRAIL

Lower Extremity Ischemia Clinical Trial

Official title:
Prospektive, Randomisierte Multicenter-Studie Zur Optimierung Der Therapie Der Akuten Ischämie Der Unteren Extremitäten Durch Die Kontrollierte Extremitätenreperfusion (Prospective, Randomized Multicenter - Study for Optimization of Therapy of the Acute Ischemic Limb by Controlled Reperfusion)

Status Terminated

Clinical Trial Summary

The purpose of this study is to prove the findings of a preliminary study which strongly suggest the hypothesis that the result of conventional embolectomy for acute, severe lower-limb ischemia can be improved by controlled reperfusion.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Lower Extremity Ischemia

Clinical Trial Details

NCT number	NCT00567801
Study type	Interventional
Source	University Hospital Freiburg
Contact
Status	Terminated
Phase	Phase 3
Start date	September 2002
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01903044` - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating	Phase 1/Phase 2
Completed	`NCT00693823` - Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Femoral Artery Occlusive Disease	N/A
Completed	`NCT00962897` - Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Femoral Artery Occlusion	N/A
Completed	`NCT00753025` - Autologous Bone Marrow For Lower Extremity Ischemia Treating	Phase 2
Recruiting	`NCT04912323` - Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease	N/A